A carregar...
Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma
Carfilzomib is a second-generation proteasome inhibitor with well-documented clinical activity as a single agent in patients with relapsed/refractory multiple myeloma. Carfilzomib can partially overcome resistance in bortezomib-refractory patients and has significant efficacy in bortezomib-naïve pat...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3463411/ https://ncbi.nlm.nih.gov/pubmed/23055749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S28911 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|